Lindsey Shapiro, PhD, science writer —

Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.

Articles by Lindsey Shapiro

MYELOMA

September 26, 2022 by Lindsey Shapiro, PhD

Trial to Test Abecma in Patients With Poor Stem Cell Transplant Response

An upcoming clinical trial will evaluate the CAR T-cell therapy Abecma (idecabtagene vicleucel) in people newly diagnosed with multiple myeloma who had a…

MYELOMA

April 11, 2022 by Lindsey Shapiro, PhD

Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

More than 30 million people in 46 countries joined together to participate in Myeloma Action Month (MAM), a campaign in March to raise awareness…

MYELOMA

February 28, 2022 by Lindsey Shapiro, PhD

IMF Opening ‘Action’ Campaign to Mark Myeloma Awareness Month

The International Myeloma Foundation (IMF) is opening its annual Myeloma Action Month (MAM) campaign with a variety of events and undertakings…

Lindsey Shapiro, PhD, science writer —

Articles by Lindsey Shapiro

Trial to Test Abecma in Patients With Poor Stem Cell Transplant Response

Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

IMF Opening ‘Action’ Campaign to Mark Myeloma Awareness Month

Recent Posts